Orexa: Funding, Investors & Team (Sep 2026)
A phase 2 pharmaceutical firm called Orexa creates and sells treatments meant to encourage eating. Its lead substance, ORE-001, is an oral formulation that is proprietary and is based on a well-known anaesthetic. The business has begun its initial phase 2a trial on Post-Operative Ileus Prevention. Additionally, phase 2a studies on anorexia and cachexia are being prepared. Increased food consumption could result in better patient health, a shorter hospital stay, and significant cost savings with these three indicators. Orexa was established in 2016 and has its headquarters in Herpen, Netherlands (Oss Region, Noord Brabant). favourable risk/reward: lower risk due to the active ingredient's long history of use; lean and rapid development process; highly appealing market potential
Orexa has raised $520k across 1 funding round on record, the most recent an undisclosed round of $520k announced in Jan 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Orexa Company Profile and Key Stats
Latest funding round on record: Jan 2023.
Orexa Funding Rounds
Orexa Founders and Leadership Team
No contact details are on record for this team yet.
Orexa Funding Compared to Other Biotechnology Startups
Orexa's latest round of $520k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Orexa in Biotechnology and Oss
Companies Similar to Orexa
The Protein Brewery is a high-tech company that specializes in developing and making animal-free- based…
Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral…
Onward is creating an Implantable Neuro-stimulation System (INS) that includes real-time motion feedback and…
Scinvivo is a medical technology company. Scinvivo is involved in bladder cancer medical needs. They provide…
Revyve produces animal-free food ingredients from microorganisms. The company's premium ingredients include…
Merus is dedicated to creating superior treatments for cancer patients and potentially finding a cure. Our…
Salvia BioElectronics is dedicated to creating new neuromodulation devices to help treat migraines. They are…
We are a clinical-stage pharmaceutical company discovering and developing therapies targeting mitochondrial…
QurieGen is a biotechnology company that speeds up the process of finding and creating new drugs.
Protix Biosystems is a biometrics company that offers a range of products which enable its customers to…
QDI Systems is a startup company that engages in the development of advanced imaging devices for medical…
BIMINI Biotech, a startup established in 2019 in Leiden, The Netherlands, focuses on creating groundbreaking…
Orexa Funding FAQs
What does Orexa do?
A phase 2 pharmaceutical firm called Orexa creates and sells treatments meant to encourage eating. Its lead substance, ORE-001, is an oral formulation that is proprietary and is based on a well-known anaesthetic. The business has begun its initial phase 2a trial on Post-Operative Ileus Prevention. Additionally, phase 2a studies on anorexia and cachexia are being prepared. Increased food consumption could result in better patient health, a shorter hospital stay, and significant cost savings with these three indicators. Orexa was established in 2016 and has its headquarters in Herpen, Netherlands (Oss Region, Noord Brabant). favourable risk/reward: lower risk due to the active ingredient's long history of use; lean and rapid development process; highly appealing market potential
How much funding has Orexa raised?
Orexa has raised $520k across 1 round on record. The most recent is an undisclosed round of $520k announced in Jan 2023.
When did Orexa last raise funding?
Orexa's most recent funding round on record is an undisclosed round of $520k, announced in Jan 2023.
Who is the CEO of Orexa?
Sake Stevenhaagen is listed as CEO at Orexa.
Where is Orexa headquartered?
Orexa is based in Oss, Noord-Brabant, Netherlands.
How many employees does Orexa have?
Orexa is in the 1-10 employee band.
How does Orexa's funding compare to other Biotechnology startups?
Orexa's latest round of $520k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Orexa Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Orexa is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.